Regeneron’s earnings boosted by demand for blockbuster eye drug Eylea
Read more at MarketWatch
-
PepsiCo earnings beat estimates, but demand for drinks and snacks drops in North America
PepsiCo's earnings topped Wall Street's estimates, but the company's revenue missed expectations, as drink and snack demand fell in North America.CNBC - 2h -
Rangers land Miller in blockbuster with Canucks
J.T. Miller is headed back to the Rangers in a blockbuster deal with the Canucks, who will receive Filip Chytil, Victor Mancini and a 2025 first-rounder in return.ESPN - 3d -
Apple’s Blockbuster Earnings Mask Its Fading Innovation
Apple reported record quarterly revenue but saw China iPhone sales drop.Inc. - 4d -
Elevance Health earnings boost health-insurance stocks after upbeat outlook
Elevance Health Inc.’s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor ...MarketWatch - Jan. 23 -
Weight-loss drugs may boost health in many ways, say researchers
New weight-loss drugs have broad health benefits but also come with risks, researchers warn.BBC News - Jan. 20 -
JPMorgan, Citi, Wells Fargo and Goldman’s earnings results may boost banks stocks further
The largest banks in the U.S. may justify further gains in stock prices if their earnings updates in the coming days include any upside surprises around loan growth or a boost from lighter ...MarketWatch - Jan. 13 -
High cost of weight loss drugs drives employers to require nutrition counseling, in boost for startups
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.CNBC - Jan. 10 -
‘All eyes are on Glasgow’: UK’s first legal drug consumption room ready to open
The Thistle will be available 365 days a year and provide a supervised space where drugs can be injected safely. The UK’s first legal drug consumption room, the Thistle, will open its doors in the ...The Guardian - Jan. 10 -
Smith dumps Diageo stake over impact of weight-loss drugs on alcohol demand
Veteran stockpicker sells shares in spirits brand because drinks sector is being ‘impacted negatively’Financial Times - Jan. 9
More from MarketWatch
-
Trump has two strong options to defuse the U.S. debt time-bomb. He should use them.
AI-fueled productivity growth, combined with realistic and constructive immigration reform, would put the U.S. economy on more solid footing.MarketWatch - 13m -
The end of insurance: Climate change is destroying homeowners and insurers
Traditional insurance models aren’t able to handle escalating natural disaster risks.MarketWatch - 17m -
Trump, tariffs and your 401(k) — why it’s time to diversify
Putting all your eggs in one basket is an especially bad idea now.MarketWatch - 53m -
People who make under $130,000 were already cutting back. Trump’s trade war will tighten the squeeze.
Middle-income households are feeling financially stressed and negative about their financial outlook, and many are cutting spending for 2025.MarketWatch - 1h -
Job openings fall close to 4-year low. Finding work gets harder.
It’s gotten harder for the unemployed to find work. Job openings in the U.S. fell at the end of 2024 to the second-lowest level since the end of the pandemicMarketWatch - 1h
More in Business
-
Trump has two strong options to defuse the U.S. debt time-bomb. He should use them.
AI-fueled productivity growth, combined with realistic and constructive immigration reform, would put the U.S. economy on more solid footing.MarketWatch - 13m -
New York Law Seeks to Protect Abortion-by-Mail Providers
The new law in New York expands the state’s shield laws for healthcare providers.Inc. - 14m -
The end of insurance: Climate change is destroying homeowners and insurers
Traditional insurance models aren’t able to handle escalating natural disaster risks.MarketWatch - 17m -
Will This New GLP-1 Drug be More Powerful Than Ozempic?
Investors seek answers on Novo Nordisk’s next-gen obesity drug, CagriSema.Inc. - 20m -
Stockpiling ahead of higher tariffs is a big mistake, experts say
Experts weigh in on how the urge to hoard certain goods ahead of potentially higher prices can backfire.CNBC - 21m